Net profit of Procter & Gamble Health rose 25.56% to Rs 82.33 crore in the quarter ended September 2024 as against Rs 65.57 crore during the previous quarter ended September 2023. Sales rose 2.78% to Rs 313.41 crore in the quarter ended September 2024 as against Rs 304.93 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
| Sales | 313.41 | 304.93 | 3 |
| OPM % | 36.39 | 29.08 | - |
| PBDT | 117.17 | 94.53 | 24 |
| PBT | 111.40 | 88.05 | 27 |
| NP | 82.33 | 65.57 | 26 |